Inhibikase Therapeutics IKT
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 1.62 | 73 | -15.60 | -12 | -14.16 | 80 |
| 2025Q2 | 1.95 | 80 | -11.96 | -10 | -10.83 | 89 |
| 2025Q1 | 2.19 | 86 | -15.15 | -14 | -14.18 | 94 |
| 2024Q4 | 3.25 | 95 | -12 | -23.56 | 99 | |
| 2024Q3 | 1.30 | -1 | -6 | -87.52 | 4 | |
| 2024Q2 | 1.21 | 5 | -83.54 | -5 | -49.86 | 9 |
| 2024Q1 | 2.16 | 7 | -52.38 | -5 | -36.36 | 11 |
| 2023Q4 | 1.27 | 11 | -32.14 | -4 | -25.80 | 15 |
| 2023Q3 | 1.39 | 15 | -26.65 | -5 | -22.84 | 18 |
| 2023Q2 | 3.61 | 19 | -25.80 | -6 | -22.88 | 22 |
| 2023Q1 | 3.95 | 25 | -19.32 | -4 | -16.87 | 28 |
| 2022Q4 | 3.00 | 21 | -18.54 | -4 | -15.99 | 25 |
| 2022Q3 | 5.46 | 25 | -16.45 | -4 | -14.37 | 29 |
| 2022Q2 | 4.46 | 30 | -14.61 | -5 | -12.82 | 34 |
| 2022Q1 | 8.88 | 34 | -12.82 | -5 | -11.48 | 38 |
| 2021Q4 | 8.82 | 38 | -12.36 | -5 | -11.42 | 42 |
| 2021Q3 | 11.40 | 43 | -9.91 | -4 | -9.40 | 46 |
| 2021Q2 | 16.80 | 47 | -9.57 | -3 | -8.63 | 49 |
| 2021Q1 | 36.06 | 8 | -29.59 | -3 | -19.78 | 12 |
| 2020Q4 | 41.40 | 10 | -1 | -14.87 | 15 |